PHARMALINEA D.O.O.
About
Company description
PharmaLinea develops and manufactures clinically supported private label food supplements, fit for best-quality brands and promotion through medical detailing. Our portfolio covers indications such as iron deficiency, immunity, urinary tract, pain, prediabetes, sleep, fertility, bone health, digestive, and eye health. Our products are present in over 40 markets worldwide and several have achieved market-leading positions. Companies from global groups, such as Stada or Teva, choose us because our products provide differentiation, and the accompanying clinical evidence convinces doctors. We are part of the Vitafoods Steering Committee and recipients of a NutraIngredients Award. We take pride in basing our products on sound clinical evidence and even conducting best-quality clinical trials on our formulations, as we believe this is the way forward for the supplement industry.
Quick facts
Sales markets | Africa; Asia; Central/South America; Eastern Europe; Middle East; North America; Western Europe |
---|---|
Primary business activity | Contract Manufacturer |
Affiliated categories: | Food Supplements / Nutraceuticals |Herbal products and remedies |Private label/Bespoke products More |
Upcoming events
Vitafoods Europe 2024
14 - 16 May 2024 - Geneva, Switzerland Visit us at stand K110 Book a meeting See our Exhibitor Profile See full Exhibitor ListRecently at
Vitafoods Europe Online and In-Person
1 - 12 May 2023 - Online We were at stand L102 See our Exhibitor Profile See full Exhibitor ListNews about PHARMALINEA D.O.O.
30 Apr 2024
PharmaLinea to showcase new developments at Vitafoods Europe
At Vitafoods Europe, PharmaLinea will present several new products, new development projects, and new clinical trial results at stand K110
Read more8 Apr 2024
Why should science-based brands invest in doctor-driven influencer marketing?
PharmaLinea has recently seen an uptick in cases where doctor or pharmacist influencers are creating outstanding results
Read more12 Mar 2024
Nutraceutical market trends for 2024
In a recent webinar with IQVIA, which regularly attracts over 1000 registrants, PharmaLinea highlights the following trends to look out for
Read more7 Mar 2024